|
Product
selection and development at Erica is based on two core objectives.
First, to offer high quality generic medicines at rational prices, and
second, to provide novel dosage forms that score over existing
therapies.
Regulated markets
Erica's
focus segment is generics for the Regulated markets of USA and Europe.
Erica has strong infrastructure to develop the products and dossiers in
line with regulatory requirements. List of available products and
pipeline can be provided on request. You can write to us at erica@ericagroup.com for product list. Please give us your company name, country, contact person and telephone number .
Semi Regulated markets
Our product
basket consists of antimalarials, anti-infectives and nutritional
supplements.
erica's
focus on "Malaria"
Africa being our important market we focus on malaria which is a
major” killer disease”. Each year 300-500 million cases of
malaria occur and 90% of them in Sub-Saharan Africa.
Erica
is poised to meet these challenges with a range of affordable products
for all age-groups and common forms of malaria. Novel antimalarial
combinations as per WHO guidelines are developed to tackle resistance
and Erica is developing convenient dosage forms for malaria treatment
especially for children.
|